Crossref journal-article
Springer Science and Business Media LLC
European Journal of Pediatrics (297)
Bibliography

Fischer, A., Segal, A. W., Seger, R., & Weening, R. S. (1993). The management of chronic granulomatous disease. European Journal of Pediatrics, 152(11), 896–899.

Authors 4
  1. A. Fischer (first)
  2. A. W. Segal (additional)
  3. R. Seger (additional)
  4. R. S. Weening (additional)
References 16 Referenced 43
  1. Cohen MS, Isturiz RE, Malech HL, Root RK, Wilfert CM, Gutmann L, Buckley RH (1981) Fungal infection in chronic granulomatous disease. Am J Med 71:59–62 (10.1016/0002-9343(81)90259-X) / Am J Med by MS Cohen (1981)
  2. Ezekowitz A (1991) Interferon gamma for chronic granulomatous disease. N Engl J Med 325:1516 (10.1056/NEJM199111213252115) / N Engl J Med by A Ezekowitz (1991)
  3. Ezekowitz RAB, Dinauer MC, Jaffe HS, Orkin SH, Newburger PE (1988) Partial correction of the phagocyte defect in patients with X-linked chronic granulomatous disease by subcutaneous interferon gamma. N Engl J Med 319:146–151 (10.1056/NEJM198807213190305) / N Engl J Med by RAB Ezekowitz (1988)
  4. Ezer G, Soothill J (1974) Intracellular bactericidal effects of rifampicin in both normal and chronic granulomatous disease polymorphs. Arch Dis Child 4:463–466 (10.1136/adc.49.6.463) / Arch Dis Child by G Ezer (1974)
  5. Hoger PH, Seger RA, Schaad UB, Hitzig WH (1985) Chronic granulomatous disease: uptake and intracellular activity of fosfomycin in granulocytes. Pediatr Res 19:38–44 (10.1203/00006450-198501000-00011) / Pediatr Res by PH Hoger (1985)
  6. Huizinga TWJ, Van der Schoot CE, Roos D, Weening RS (1991) Induction of neutrophil FC-γ receptor 1 expression can be used as a marker for biologic activity of recombinant interferon-γ in vivo. Blood 77:2088–2090 (10.1182/blood.V77.9.2088.2088) / Blood by TWJ Huizinga (1991)
  7. The International Chronic Granulomatous Disease Cooperative Group (1991) A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. N Engl J Med 324:509–516 (10.1056/NEJM199102213240801) / N Engl J Med by The International Chronic Granulomatous Disease Cooperative Group (1991)
  8. Margolis DM, Melwick DA, Alling DW, Gallin JL (1990) Trimethoprim-sulfamethoxazole phrophylaxis in the management of chronic granulomatous disease. J Inf Dis 162:723–726 (10.1093/infdis/162.3.723) / J Inf Dis by DM Margolis (1990)
  9. Mouy R, Fischer A, Vilmer E, Seger R, Grisecelli C (1989) Incidence, severity and prevention of infections in chronic granulomatous disease. J Pediatr 114:555–560 (10.1016/S0022-3476(89)80693-6) / J Pediatr by R Mouy (1989)
  10. Mouy R, Seger R, Bourquin JP, Veber F, Blanche S, Griscelli C, Fischer A (1991) Interferon gamma for chronic granulomatous disease. N Engl J Med 325:1516–1516 (10.1056/NEJM199111213252115) / N Engl J Med by R Mouy (1991)
  11. Muhlebach TJ, Gabay J, Nathan CF, Erny C, Dopfer G, Schroten H, Wahn V, Seger RA (1992). Treatment of patients with chronic granulomatous disease with recombinant human interferon-gamma does not improve neutrophil oxidative metabolism, cytochrome b558 content or levels of four antimicrobial proteins. Clin Exp Immunol 88:203–206 (10.1111/j.1365-2249.1992.tb03062.x) / Clin Exp Immunol by TJ Muhlebach (1992)
  12. Sechler JMG, Malech HL, White CJ, Gallin JL (1988) Recombinant human interferon-g reconstitutes defective phagocyte function in patients with chronic granulomatous disease of childhood. Proc Natl Acad Sci USA 85:4874–4878 (10.1073/pnas.85.13.4874) / Proc Natl Acad Sci USA by JMG Sechler (1988)
  13. Segal AW (1989) The electron transport chain of the microbicidal oxidase of phagocytic cells and its involvement in the molecular pathology of chronic granulomatous disease. J Clin Invest 83:1785–1793 (10.1172/JCI114083) / J Clin Invest by AW Segal (1989)
  14. Seger R, Baumgartner S, Tiefenauer L, Gmunder F (1981) Chronic granulomatous disease: effect of sulfamethoxazole/trimethoprim on neutrophil microbicidal function. Helv Paediatr Acta 36:579–588 / Helv Paediatr Acta by R Seger (1981)
  15. Weening RS, Kabel P, Pijman P, Roos D (1983) Continuous therapy with sulfamethoxazole-trimethoprim in patients with chronic granulomatous disease. J Pediatr 103:127–130 (10.1016/S0022-3476(83)80798-7) / J Pediatr by RS Weening (1983)
  16. Woodman RC, Erickson RW, Rea J, Jaffe HS, Curnutte JT (1992) Prolonged recombinant interferon-gamma therapy in chronic granulomatous disease: evidence against enhanced neutrophil oxidase activity. Blood 79:1558–1562 (10.1182/blood.V79.6.1558.1558) / Blood by RC Woodman (1992)
Dates
Type When
Created 20 years, 1 month ago (Aug. 2, 2005, 3:04 a.m.)
Deposited 5 years, 4 months ago (April 8, 2020, 10:57 a.m.)
Indexed 2 months ago (June 30, 2025, 7:27 a.m.)
Issued 31 years, 10 months ago (Nov. 1, 1993)
Published 31 years, 10 months ago (Nov. 1, 1993)
Published Print 31 years, 10 months ago (Nov. 1, 1993)
Funders 0

None

@article{Fischer_1993, title={The management of chronic granulomatous disease}, volume={152}, ISSN={1432-1076}, url={http://dx.doi.org/10.1007/bf01957525}, DOI={10.1007/bf01957525}, number={11}, journal={European Journal of Pediatrics}, publisher={Springer Science and Business Media LLC}, author={Fischer, A. and Segal, A. W. and Seger, R. and Weening, R. S.}, year={1993}, month=nov, pages={896–899} }